Testing a tool to predict antibiotic-resistant infections in ICU patients
Part of Infections clinical trials.
This study validates a prediction tool designed to identify which ICU patients are at risk of developing multidrug-resistant gram-negative bacteria (a serious infection resistant to many antibiotics). The tool may help doctors start appropriate treatment earlier and improve patient outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You stayed in an ICU for at least 48 hours
- A sample (blood, urine, or other fluid) was collected and tested for infection within 48 hours of your ICU admission
- Your medical records and lab results are available in the hospital's electronic systems
- This is your first ICU stay at this hospital during this illness (if you've been admitted to the ICU multiple times, only the first stay counts)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a quality improvement program to help ICUs use fewer antibiotics without compromising patient safety. It looks at how well the intervention works to reduce antimicrobial use in critically ill patients.
This study tests a computer tool that helps doctors give the right dose of strong antibiotics to ICU patients. It is for adults who have recently started one of two specific antibiotics.
This study looks at whether a simple rectal swab test can help predict the risk of developing infections that are resistant to common antibiotics. It focuses on patients in the intensive care unit (ICU) who have already had this swab done as part of their care.
This study tests a new computer program that helps doctors find serious infections (sepsis and bacteremia) earlier in ICU patients. If you join, the program will analyze your health data to see if it can better predict these infections, which could help you get faster treatment.
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
This study will track how certain hard-to-treat bacteria spread and cause infections in people who are in the intensive care unit (ICU) or have had a stem cell transplant. The goal is to better understand and prevent these infections in vulnerable patients.
Hear when a new Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.